a year ago
ROIV
AnalystsNeena Bitritto-GargNeena Bitritto-Garg's Stock Forecasts
AnalystsNeena Bitritto-Garg
Analyst Ranking
Top 12%
#576 out of 4867 analysts
Average Return
+12.52%
Win Rate
49%34 out of 69
Risk vs Reward
Poor
Good
Neena Bitritto-Garg's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +319.19% | $4.69 | $19.66 | 2023-03-08 - 2024-03-08 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +269.80% | $5.53 | $20.45 | 2023-03-05 - 2024-03-05 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +213.54% | $8.57 | $26.87 | 2022-05-24 - 2023-05-24 | Strong Buy |
Anaptysbio IncANAB | +193.93% | $24.71 | $72.63 | 2017-07-10 - 2018-07-11 | Buy |
Roivant Sciences LtdROIV | +165.62% | $4.13 | $10.97 | 2022-08-15 - 2023-08-15 | Strong Buy |
Neena Bitritto-Garg Analyst Color
Get additional color on Neena Bitritto-Garg's coverage of popular stocks
a year ago
AMLX
2 years ago
ROIV
3 years ago
PRTA
3 years ago
ROIV
3 years ago
PEARQ
3 years ago
NBIX
Neena Bitritto-Garg's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Acadia Pharmaceuticals IncACAD | 16 | Hold | $22.00 | +52.46% | Initiates Coverage On | 3 months ago |
Roivant Sciences LtdROIV | 5 | Strong Buy | $15.00 | N/A | Maintains | a year ago |
Amylyx Pharmaceuticals IncAMLX | 7 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $227.00 | N/A | Initiates Coverage On | a year ago |
Immunovant IncIMVT | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | a year ago |
Neurocrine Biosciences IncNBIX | 7 | Strong Buy | $136.00 | N/A | Initiates Coverage On | a year ago |
Compass Pathways PLCCMPS | 4 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Prothena Corp Public Ltd CoPRTA | 5 | Strong Buy | $62.00 | N/A | Initiates Coverage On | a year ago |
Alector IncALEC | 6 | Strong Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Sage Therapeutics IncSAGE | 6 | Hold | $21.00 | N/A | Initiates Coverage On | a year ago |
Sarepta Therapeutics IncSRPT | 2 | Strong Buy | $109.00 | N/A | Initiates Coverage On | a year ago |
Acumen Pharmaceuticals IncABOS | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $17.00 | N/A | Maintains | 2 years ago |
Atai Life Sciences NvATAI | 4 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Pear Therapeutics IncPEARQ | 3 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Passage Bio IncPASG | 2 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Decibel Therapeutics IncDBTX | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Kodiak Sciences IncKOD | 4 | Strong Sell | $6.00 | N/A | Downgrades | 3 years ago |
Alpha Tau Medical LtdDRTS | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 3 years ago |
Arena Pharmaceuticals IncARNA | 2 | Hold | $100.00 | N/A | Downgrades | 3 years ago |
Zogenix IncZGNX | 1 | Hold | $27.00 | N/A | Initiates Coverage On | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Strong Buy | $192.00 | N/A | Initiates Coverage On | 5 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 5 years ago |
Insmed IncINSM | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 8 years ago |
Anaptysbio IncANAB | 1 | Buy | $36.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.